|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Clearing Regulatory Hurdles
Author(s)Christopher C. DeMerlis
The authors propose several models for independent evaluation of new excipients.
Advertisement
Articles in this issue
about 22 years ago
FDA Will Drive Changes for Contract Businessabout 22 years ago
In the Spotlight--Decemberabout 22 years ago
Novemember 2003about 22 years ago
FDA Seeks Risk-Based Inspection Programabout 22 years ago
Routine Sample Size for a Retest Procedureabout 22 years ago
November 2003about 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
5